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Ethnopharmacological relevance: Although serotherapy against snakebite has been discovered more
than one hundred years ago, antivenom is not available all over Brazil. The use of plants from folk
medicine is common mainly in the Brazilian Amazon area. One of these plants is named Humirianthera
ampla (HA).
Materials and Methods: We have investigated HA extract and constituents’ antiophidic activity in
different experimental protocols against some Bothrops snake venoms (Bothrops jararacussu, Bothrops
atrox and Bothrops jararaca). The protocols investigated include phospholipase, proteolytic, pro-coagulant,
hemorrhagic, edematogenic and myotoxic activities induced by these venoms in Swiss mice.
Results: All the venoms caused an increase in the rate of creatine kinase (CK) release from isolated
muscles, indicating damage to the sarcolemma. The crude extract of HA decreased the myotoxic activity
in a concentration-dependent fashion. The presence of HA 300 mg/mL decreased up to 96% of Bothrops
jararacussu and 94% of Bothrops atrox myotoxicity after 90 min of exposure. In vivo myotoxicity of
Bothrops atrox venom was decreased in 75% when the venom was preincubated with HA 500 mg/kg.
Similar results were observed with lupeol against Bothrops jararacussu and Bothrops atrox venoms. The
hemorrhagic activity was evaluated by intradermal injection of Bothrops atrox venom. Preincubation and
oral pre- and posttreatment with HA decreased hemorrhage by 100%, 45% and 45%, respectively. Bothrops
atrox venom also induced formation of edema, which was signiﬁcantly inhibited by pre- and posttreat-
ment with HA. All the venoms showed extensive pro-coagulating properties, and these activities were
inhibited by up to 90% with HA, which presented concentration-dependent inhibition. Finally, proteolytic
and phospholipase activities of the venoms were all inhibited by increasing concentrations of HA, lupeol
and sitosterol. The inhibition of these activities might help explain the actions against in vivomyotoxicity
and the in vivo effects observed, i.e., edema, myotoxicity, pro-coagulation and hemorrhage.
Conclusions: Altogether, our results give support for the popular use of HA extracts in cases of accidents
with snakes, suggesting that it can be used as an adjunct in the management of venomous snakebites.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction
Venomous snakebites represent a signiﬁcant health problem,
especially in tropical countries, where they frequently affect
young and economically active men working in the countryside.
In Brazil, most accidents are caused by snakes belonging to
Bothrops genus, which induce extensive local damage, such as6.
r.
r the Elsevier OA license. myonecrosis and edema (Bochner and Struchiner, 2003; Da Silva
et al., 2003).
The treatment available for these accidents is antibothropic
antivenom, which has low and limited effectiveness against the
local effects of venoms (Da Silva et al., 2003). The antivenom
therapy is often administered late after the accident, when tissue
destruction is already in process, causing irreversible and dis-
abling damage (Gutie´rrez et al., 1980; Homma and Tu, 1971;
Nishioka et al., 1992; Rosenfeld, 1971). The use of plants to halt
the effect of snake venoms has been proposed by previous studies
(Alam and Gomes, 2003; Borges et al., 2005; Cavalcante et al.,
2007; Oliveira et al., 2005; Tan et al., 2009). Therefore, our group
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effective pharmacologically active principles from plants used in
folk medicine to treat or prevent damage caused by accidents
with venomous snakes. For example, we have proposed the use of
Eclipta prostrata (Asteraceae) and constituents as an alternative
way to prevent some actions of crotalid venoms (Melo et al.,
1994; Mors et al., 1989).
In the valley of Purus, Amazon region, rural communities that
have no immediate medical treatment make use of the ethanolic
extract obtained from the roots of the plant Humirianthera ampla
Miers, aiming to slow the effects of toxins in snakebites, mainly
Bothrops atrox, and to achieve some relief for the victims,
although up to date there are no scientiﬁc data supporting the
antiophidic effect (Graebner et al., 2000). Humirianthera ampla
Miers is a member of the Icacinaceae family that is popularly
known as ‘‘surucucaı´na’’ or ‘‘surucuı´na’’. Studies of chemical
constituents of this plant revealed the presence of the di- and
triterpenoids: annonalide, humirianthol, acrenol and lupeol
(Dessoy and Scher, 2002; Luiz et al., 2007). In addition, substances
as b-sitosterol and glycosylated sitosterol were also isolated from
the ethanolic extract (EE) of Humirianthera ampla roots (Graebner
et al., 2000, 2002; Luiz et al., 2007). The presence of these
compounds might explain the exceptional effect of the Humir-
ianthera ampla against inﬂammation and pain caused by snake
bite and consequently validates the large use of this plant by the
Amazonia native people in this condition. In the present study,
the Humirianthera ampla extract and the isolated compounds
were investigated under different experimental protocols in vivo
using Bothrops atrox venom and in vitro using Bothrops jararaca,
Bothrops jararacussu and Bothrops atrox venoms.2. Material and methods
Bothrops jararaca and Bothrops jararacussu venoms were
obtained from Instituto Vital Brasil, Rio de Janeiro; Bothrops atrox
venom was obtained from Embrapa, Goia´s; creatine kinase (CK)
activity was determined using a CK NACs kit from BIOCLIN;
lupeol and sitosterol were purchased from Sigma-Aldrich Co.;
acrenol, annonalide and humirianthol were provided by Dr.
Ademir Farias Morel from the Federal University of Santa Maria,
Rio Grande do Sul. Male Swiss mice were provided by the Rodent
Vivarium of the Institute of Microbiology Paulo de Go´es—Federal
University of Rio de Janeiro. Mice weighing 25.071.0 g used for
the study received water and food ad libitum and were kept under
a natural light cycle. We adhered to protocols approved by the
Ethics Committee for the Use of Animals of the Federal University
of Rio de Janeiro (CEUA-UFRJ), where all the procedures that could
cause pain were performed under anesthesia.2.1. Plant material
Humirianthera ampla was collected in November 2006 in Porto
Velho, State of Rondoˆnia, Brazil, where it is quite abundant (S 081
410 09.915300; W 0631 520 10.0200). The material was collected by
Dr. Mariaˆngela Soares de Azevedo’s staff group and was identiﬁed
by a member of the Department of Botany, INPA, Manaus, Brazil,
and a voucher specimen was deposited in the Herbarium Dr. Ary
Tupinamba´ Penna Pinheiro (Porto Velho-RO, Brazil) under the
number 214579.
The ethanolic extract was prepared from the root (1.562 kg),
which was triturated and dried at room temperature. The dried
plant material was placed in contact with ethanol and stirred for a
period of 8 h. The material was ﬁltered and the solvent evapo-
rated under reduced pressure, yielding 83.21 g of extract.2.2. Extraction and isolation
Air dried, powdered roots of Humirianthera ampla were
extracted exhaustively with ethanol at room temperature. Dry
ethanol extract was dissolved in H2O and the solution was
successively partitioned between hexane, CH2Cl2, EtOAc and n-
BuOH. The CH2Cl2 fraction was subjected to silica gel CC with
CHCl3–MeOH mixtures to yield annonalide, humirianthol and
acrenol (Graebner et al., 2000).
2.3. Myotoxicity in vitro
In order to assess the loss of creatine kinase from muscle cells,
which indicates damage to the sarcolemma, in vitro assays were
performed as previously described (Melo and Suarez-Kurtz,
1988a; Melo et al., 1993; 1994). Brieﬂy, mouse extensor digitorum
longus (EDL) muscle was removed, weighed and superfused
continuously with physiological saline solution (PSS), which was
composed of (mM): NaCl, 135; KCl, 5; CaCl2, 2; MgCl2, 1; NaHPO4,
1; NaHCO3, 15; and dextrose, 11. The pH of this solution was
equilibrated to 7.3 with 5% CO2/ 95% O2. During the superfusion,
the muscles were exposed to the venoms of Bothrops jararaca,
Bothrops jararacussu and Bothrops atrox (25 mg/mL), Humirianthera
ampla ethanolic crude extract (HA, 100–300 mg/mL) and lupeol
(100 mM) that were added to the PSS. Perfusion samples were
collected at 30 min intervals and replaced with fresh solution.
The collected samples were stored at 4 1C and their CK activity
was determined according to previously described procedures
(Melo and Suarez-Kurtz, 1988a; 1988b).
2.4. Myotoxicity in vivo
We evaluated the myotoxicity of Bothrops atrox venom by
measuring the increase of plasma CK activity induced by intra-
muscular (i.m.) injection of venom alone or associated with
Humirianthera ampla ethanolic crude extract or lupeol. The venom
was dissolved in PSS to a ﬁnal volume of 0.1 mL (1.0 mg/kg) and
they were injected into the rear thigh of the mice as described
previously (Melo and Suarez-Kurtz, 1988b; Melo et al., 1993;
1994). Negative controls consisted of mice injected with the same
volume of PSS. To evaluate the antimyotoxic activity of the
Humirianthera ampla ethanolic crude extract and lupeol, three
different protocols were used: preincubation: Venom dissolved in
PSS was ﬁrst incubated with the extract (300 mg/kg) or lupeol
(10 mg/kg) for 15 min at room temperature prior to injection;
pretreatment: 0.2 mL of the extract (1000 mg/kg) or lupeol
(10 mg/kg) was administered orally and intraperitoneously (i.p.),
respectively, 15 min before the i.m. venom injection; post-treat-
ment: 0.2 mL of the extract (1000 mg/mL) or lupeol (10 mg/kg)
was administered orally and intraperitoneously (i.p.) 15 min after
the i.m. venom injection. The doses used here were based on the
dose-response study (not shown), from where we chose the most
effective ones.
2.5. Hemorrhagic activity
The hemorrhagic effect was induced by an intradermic (i.d.)
injection of 0.1 mL of Bothrops atrox venom (1 mg/kg) in the
abdomen of mice and quantiﬁed as previously described (Melo
et al., 1994). The negative control received 0.1 mL of PSS i.d.
injection. To evaluate the antihemorrhagic activity of the Humir-
ianthera ampla ethanolic crude extract, three different protocols
were used: preincubation: Bothrops atrox dissolved in PSS was
ﬁrst incubated with the extract (300 mg/kg) for 15 min at room
temperature prior to injection; pretreatment: 0.2 mL of the
extract (1000 mg/kg) was administered orally 15 min before the
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extract (1000 mg/mL) was administered orally 15 min after the
intradermic (i.d.) venom injection. The doses used here were
based on the dose-response study (not shown), from where we
chose the most effective ones.
Two hours after the venom injection, animals were killed by
ether anesthesia, and the skin covering the abdomen was
removed, stretched, and dried at room temperature for 72 h.
The skin was ﬁxed to a lucite base plate, and the entire area at
the injection site and the surrounding area were transilluminated
using an incandescent light. Light transmitted over an area of
109 mm2 was read, and light transmission or the absorbance was
normalized by taking the mean values of the readings over skin
injected with either PSS (calibrated to zero) or Bothrops atrox
venom as arbitrary units of absorbance (AU). The hemorrhagic
damage induced by the venom alone was considered as 100% of
hemorrhage induction.2.6. Proteolytic and phospholipase activities
The proteolytic assay was carried out as previously described
(Garcia et al., 1978). Bothrops jararacussu, Bothrops jararaca and
Bothrops atrox venoms (10 mg/mL) were preincubated with
Humirianthera ampla ethanolic crude extract (1–300 mg/mL)
or lupeol, sitosterol, acrenol, anonalida and humirianthol
(1–100 mM) for 30 min at 37 1C. We added the venom alone or
the mixtures in a solution containing 0.2% azocasein, 20 mM
CaCl2, and 0.2 M Tris–HCl (pH 8.8). The reaction continued for
90 min at 37 1C and was stopped by the addition of 0.4 mL of 15%
(vv) trichloracetic acid, and then centrifuged at 20,000 rpm. We
then removed 1.0 mL of the supernatant and mixed it with 0.5 mL
NaOH (2.0 M). This ﬁnal solution was analyzed by spectrophoto-
metry at an absorbance of 420 nm.
Phospholipase A2 activity was assessed by adapting the turbi-
dimetric assay described previously (Marinetti, 1965). We pre-
pared the substrate by shaking one chicken egg yolk in a solution
of 150 mM NaCl to a ﬁnal volume of 100 mL and stored it at 4 1C
prior to the reaction. In each assay, we prepared several tubes by
taking a ﬁnal volume (0.25 mL) of a 10% dilution of the egg
suspension and adding it to a solution containing 150 mM NaCl,
10 mM CaCl2, 0.01% taurocholic acid, and 5.0 mM Tris–HCl (pH
7.4). The tubes were kept at 37 1C under mild and constant
stirring during the procedure. The reactions were started by
adding 10 mg/mL of Bothrops jararacussu, Bothrops jararaca or
Bothrops atrox venom alone or preincubated for 30 min at 37 1C
with 10–500 mg/mL of the Humirianthera ampla extract or with
isolated substances (1–100 mM). Thirty minutes after starting the
reactions, the absorbance of the solutions was read at 925 nm,
and data was expressed as turbidity decrease.2.7. Clotting time
The clotting time was assessed by the modiﬁed Lee–White
method (Raphael, 1983). The animals were grouped (n¼4 for
each group) and about 50 mL of blood were collected from the
orbital plexus using heparinized microhematocrit capillary tubes.
Before collecting blood, the tubes were ﬁlled with 20 mL of PSS,
Bothrops jararacussu, Bothrops jararaca or Bothrops atrox crude
venoms (1 mg/mL); or venom preincubated with Humirianthera
ampla ethanolic crude extract (1–30 mg/mL). The extract alone
was also tested, to evaluate whether the Humirianthera ampla
extract could change the clotting time compared to control time
(capillaries with PSS). The clotting time was evaluated and
compared among the different groups.2.8. Mouse tail bleeding time evaluation
Tail vein bleeding tests were performed on mice by a modiﬁed
method, as previously described (Broze et al., 2001). Bothrops atrox
venom was administered (0.1 mg/kg, i.v.) in anesthetized mice
(intramuscular injection of 0.05 mL anesthetic mixture; pentobar-
bital 40 mg/kgþxylazine 2.5 mg/kg). Several minutes later, the
mice were immobilized in a restraint device and had their tails cut
4 mm from the tip and immersed in 5.0 mL of distilled water at
room temperature. Blood loss was evaluated one hour later as a
function of absorbance at 540 nm due to the hemoglobin content
in the water solution. The absorbance detected for a group that
received saline rather than venom was taken as a control of blood
loss, and the bleeding time of each procedure was expressed as
units of absorbance in 540 nm. For evaluation of the antiophidic
activity, three treatment protocols were used: the venom was
preincubated at 37 1C with the Humirianthera ampla ethanolic
crude extract (300 mg/kg) 15 min before the i.v. injection; the
extract (1000 mg/kg) was administered orally 15 min before the
venom injection; and the oral post-treatment, where the animals
received the HA extract (1000 mg/kg) 15 min after the venom
injection. The doses used here were based on the dose-response
study (not shown), from where we chose the most effective ones.
2.9. Thigh edema
The induction of edema was evaluated by an intramuscular
injection of 50 mL Bothrops atrox venom (1 mg/kg). Three treat-
ment protocols were used: the venom was preincubated at 37 1C
with the Humirianthera ampla ethanolic crude extract (300 mg/
kg) 15 min before the i.m. injection; the extract (1000 mg/kg) was
administered orally 15 min before the venom injection; and the
post-treatment, where the animals received the extract injection
(1000 mg/kg, oral) 5 min after the venom injection. The doses
used here were based on the dose-response study (not shown),
from where we chose the most effective ones. The thigh area was
measured using a caliper rule and the edema induced by the
venom was considered as 100% of edema induction.
2.10. Statistical analysis
Data were expressed as mean7SEM, and Student’s t-test was
used for statistical analysis. The p value o0.05 was used to
indicate a signiﬁcant difference between means.3. Results
3.1. Myotoxic activity
Mice isolated extensor digitorum longus (EDL) muscles were
exposed for 90 min to the venoms of Bothrops jararacussu,
Bothrops atrox and Bothrops jararaca (25 mg/mL). All the venoms
caused an increase in the rate of creatine kinase (CK) release from
muscles into the bathing media, although Bothrops jararaca
venom presented a milder in vitro myotoxic activity. The rate
of CK activity ranged from 0.2470.15 when exposed only
to physiological saline solution (PSS) up to 14.7272.77;
15.4771.86; 8.0574.02 (U g1 h1, n¼4) in the presence of
the venoms of Bothrops jararacussu, Bothrops atrox and Bothrops
jararaca, respectively. The addition of Humirianthera ampla etha-
nolic crude extract in increasing concentrations (100–300 mg/mL,
n¼4) to the bathing media reduced the rate of CK release
(Fig. 1A–C). When we added lupeol, it was able to partially inhibit
Bothrops jararacussu in vitro myotoxic activity. The rate of CK
release from isolated muscles ranged from 0.6370.17 U g1 h1
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Fig. 1. Effect of Humirianthera ampla extract and lupeol on Bothrops jararacussu, Bothrops atrox and Bothrops jararaca venoms’ myotoxic activities in vitro.
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Bothrops jararacussu venom alone (25 mg/mL) and up to only
11.7373.05 U g1 h1 when exposed to venom plus lupeol
(100 mM) for 90 min (Fig. 1D). The reason for the variability seen
in the results with Bothrops jararacussu venom alone is that the
composition of different lots of venom may exhibit variations
associated with the geographical origin, habitat, seasonal varia-
tion, diet, age and gender (Queiroz et al., 2008). That was why
each treatment was performed using the same venom lot.
Mice injected intramuscularly with the venom of Bothrops
atrox (1 mg/kg) presented, 2 h after venom injection, an increased
activity of CK in plasma, which ranged from 163.45719.63 U/L
(n¼5) in the group receiving the PSS solution, up to
1597.007154.97 U/L (n¼5) in the group receiving the venom.
Oral pre- and post-treatment with Humirianthera ampla ethanolic
crude extract (1000 mg/kg) did not signiﬁcantly inhibit the
myotoxic activity of the venom 2 h after venom injection.On the other hand, in the protocol of pre-incubation, the extract
of Humirianthera ampla (300 mg/kg) partially inhibited the in vivo
myotoxic activity of the venom of Bothrops atrox (790.46793.71)
(Fig. 2A). In another experiment, mice also received i.m. injection
of Bothrops atrox venom (1 mg/kg), and we observed, two hours
after the injections, an increase in the plasma CK activity that
reached up to 2443.917268.80 U/L, compared to 137.257
32.64 U/L from the group receiving only PSS injection. When we
preincubated the venom with lupeol (10 mg/kg) for 15 min before
i.m. injection, the plasma CK activity was in the range of
1368.617250.44 U/L (Fig. 2B).
3.2. Hemorrhagic activity
The intradermic injection of Bothrops atrox venom (1 mg/kg)
induced a severe hemorrhagic damage surrounding the region
injected, which was expressed in arbitrary units of absorbance in
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Fig. 3. Effect of Humirianthera ampla extract on Bothrops atrox venom’s hemorrhagic and bleeding activities.
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(182.25716.14 AU). The venom activity was inhibited (180.007
17.16 AU) when pre-incubated with 300 mg/kg of Humirianthera
ampla ethanolic crude extract, while the oral pre- and post-
treatment (1000 mg/kg) reduced the venom activity (539.177
47.08 and 531.25753.07 AU, respectively) (Fig. 3A). Bothrops
atrox venom (0.1 mg/kg), when injected i.v. into anesthetized
mice that subsequently had their tails cut, induced an important
increase in the tail bleeding. Preincubation and oral pretreatment
with Humirianthera ampla extract reduced the bleeding activity of
Bothrops atrox venom, while oral posttreatment did not (Fig. 3B).
3.3. Blood clotting activity
The venoms of Bothrops atrox, Bothrops jararaca and Bothrops
jararacussu (1 mg/mL) induced an intense decrease in the clotting
time of 50 mL of blood collected from the conjunctival sac of
anesthetized mice, from control values of 146.5076.05 s down to
10.3070.61 s; 17 2871.10 s and 14.6271.34 s, respectively
(Fig. 4A). The ethanolic crude extract of Humirianthera ampla
inhibited in a concentration-dependent manner the procoagulant
activity induced by the tested venoms, i.e., in the absence of HA
extract (zero) all venoms present 100% of procoagulant activity,
but as HA extract concentration increases, all three venoms lose
their ability to accelerate blood clot (Fig. 4B). The extract alonedid not change the clotting time compared to control time (data
not shown).
3.4. Edematogenic activity
Following i.m. injection of Bothrops atrox venom (1 mg/kg) into
the hind limb, the animals presented a signiﬁcant edema, com-
pared to animals injected only with PSS (41.5671.43, against
25.5070.88 mm2, respectively, 30 min after venom injection).
The limb edema induced by the venom was partially inhibited in
the protocols of oral pre- and posttreatment and preincubation
with the ethanolic crude extract of Humirianthera ampla (Fig. 5A
and B).
3.5. Phospholipase activity
The turbidimetric assay for phospholipase A2 activity showed
that the venoms of Bothrops atrox, Bothrops jararacussu and
Bothrops jararaca reduced the turbidity of egg yolk solutions
(0.36070.004; 0.31270.006 and 0.40470.008 absorbance units
at 925 nm, for the concentration of 10 mg/mL), respectively, com-
pared to the negative control (0.64170.028 absorbance units)
(Fig. 6A). The ethanolic crude extract of Humirianthera ampla
(1–500 mg/mL) decreased the enzymatic activity of 10 mg/mL of
the three venoms (inhibitions of up to 48%, 42% and 92% for the
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Fig. 5. Effect of Humirianthera ampla extract on Bothrops atrox venom’s edematogenic activity.
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lupeol presented a concentration-dependent inhibition over the
phospholipase activities of 10 mg/mL of Bothrops jararacussu and
Bothrops atrox venoms, respectively (Fig. 6C), while acrenol, humir-
ianthol and annonalide did not present any activity (data not
shown).
3.6. Proteolytic activity
The venoms of Bothrops atrox, Bothrops jararaca and Bothrops
jararacussu induced the hydrolysis of azocasein in a concentration-
dependent manner, leading to an increase in absorbance units at
420 nm (0.07470.004, 0.15370.009, 0.228þ0.015, for the concen-
tration of 10 mg/mL), when compared with the respective negative
controls (0.00870.001, 0.01470.003, 0.01270.001) (Fig. 7A).
The proteolytic activities of the venoms were inhibited in a
concentration-dependent manner by the ethanolic crude extract of
Humirianthera ampla (1–300 mg/mL) (Fig. 7B). Sitosterol and lupeol
presented a concentration-dependent inhibition over the proteolytic
activities of 10 mg/mL of Bothrops jararacussu and Bothrops atrox
venoms, respectively (Fig. 7C), while acrenol, humirianthol and
annonalide were devoid of any activity (data not shown).4. Discussion
Our results provide for the ﬁrst time an experimental and
scientiﬁc support for the use of Humirianthera ampla in cases of
accidents with Bothrops atrox, Bothrops jararacussu and Bothrops
jararaca, which had some of their venom activities inhibited in
experimental conditions by the crude extract and some of its
isolated compounds, i.e., sitosterol and lupeol.
As previously shown, i.m. injection of the Bothrops venoms
induces extensive myonecrosis in mice (Homsi-Brandeburgo
et al., 1988; Lomonte et al., 2003; Melo and Suarez-Kurtz,
1988a; 1988b; Melo et al., 1993; Queiroz et al., 1984). Our study
showed the important in vivo myotoxicity of Bothrops atrox
venom, which was inhibited by both Humirianthera ampla etha-
nolic crude extract and lupeol following preincubation with the
venom, and partially inhibited in the protocols of oral pre- and
posttreatment. This is of great importance considering the high
myotoxicity of Bothrops venoms and the lack of protection from
this activity by the available treatment, the antibothropic anti-
venom, leading to functional disabilities due to poor muscle
regeneration (Mello et al., 2000). Antimyotoxic properties of
Humirianthera ampla crude extract and lupeol were also shown
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bathing the isolated muscles. These data give support for the
treatment carried out by rural communities in the Amazon
region, which make use of the plant extract in oral prophylactic
and therapeutic preparations (Graebner et al.2002).
Local and systemic skeletal muscle degeneration is a common
consequence of envenomations due to snakebites. Phospholipases
A2 (PLA2) are important myotoxic components in Bothrops
venoms, inducing a similar pattern of degenerative events in
muscle cells. Myotoxic PLA2s bind to acceptors in the plasma
membrane, which might be lipids or proteins and which may
differ in their afﬁnity for the PLA2s. Upon binding, myotoxic PLA2s
disrupt the integrity of the plasma membrane by catalytically
dependent or independent mechanisms, provoking a pronounced
Ca2þ inﬂux which, in turn, initiates a complex series of degen-
erative events associated with hypercontraction, activation of
calpains and cytosolic Ca2þ-dependent PLA2s, and mitochondrial
Ca2þ overload (Gutie´rrez and Ownby, 2003). Our experiments
showed concentration-dependent inhibition of Bothrops atrox,
Bothrops jararaca and Bothrops jararacussu phospholipase A2
activities by Humirianthera ampla extract, as well as inhibition
of Bothrops jararacussu and Bothrops atrox by sitosterol and lupeol,
respectively. These data strongly suggest that the observed
decrease in the myotoxicity of Bothrops venoms is related to
inhibition of venom PLA2 activity.Another remarkable result was the effect of Humirianthera ampla
extract against the procoagulant and hemorrhagic activities of the
Bothrops venoms. Bleeding is one of the most relevant local and
systemic signs of envenomation by snakes of this genus. Several
types of bleeding distant from the site of the bite are observed, such
as gum bleeding, epistaxis, hemoptysis, hematuria, uterine,
intrathoracic or intrabdominal bleeding (Kamiguti and Sano-
Martins, 1995; Otero et al., 2002). Severe anemia and shock can
occur as complications of these hemorrhages causing deaths and
sequelae (Otero et al., 2000). For this reason, one of the mainstays of
treatment of these envenomations should be inhibition of bleeding.
The extract showed not only an extensive inhibitory response
against the procoagulant activities of the venoms, but also reduced
the skin hemorrhagic activity of Bothrops atrox venom. The hemor-
rhagic activity of Bothrops venoms is due to angiorrexis attributed to
metalloproteases, proteins that target the vascular wall. Among the
substrates of hemorrhagic toxins are integrins, present in the
vascular wall and the basal lamina (Baramova et al., 1990;
Bjarnason and Fox, 1994; Fujimura et al., 1995; Kamiguti et al.,
1986; 1991; Paine et al., 1992). Since some plant substances have
the ability to bind and neutralize toxins from snake venoms and
inhibit their catalytic activity in a concentration-dependent manner,
an anti-proteolytic mechanism has been proposed to explain the
effect of antihemorrhagic plant extracts (Melo and Ownby, 1999;
Melo et al., 1994). Studies have shown that Bothrops venoms contain
M.A. Strauch et al. / Journal of Ethnopharmacology 145 (2013) 50–58 57procoagulant toxins that act at various levels of the coagulation
cascade, such as batroxobin from Bothrops atrox, BjussuSP-I and BJ-
48 from Bothrops jararacussu, and jararassin-I from Bothrops jararaca
(Hofmann and Bon, 1987; Nahas et al., 1979; Sant’Ana et al., 2008;
Silva-Junior et al., 2007; Stocker and Barlow, 1976; Vieira et al.,
2004). The snake venom thrombin-like enzymes comprise a number
of serine proteases functionally and structurally related to thrombin.
Thus, these enzymes present ‘‘thrombin-like‘‘ effect, accelerating the
production of ﬁbrin (procoagulant effect), causing depletion of the
content of ﬁbrinogen, leading to hemorrhagic process (Braud et al.,
2000; Sajevic et al., 2011). Inhibition of hemorrhagic activities of
Bothrops venoms by Humirianthera ampla extract can be directly
related to the concentration-dependent ability of components of the
extract to inhibit the proteolytic activities of these venoms.
Edema is also an important effect of Bothrops venoms, which
along with tissue necrosis can be severe enough to cause functional
loss or even compartment syndrome (Anz et al., 2010). Humir-
ianthera ampla extract was able to inhibit the activity of the venom
in all protocols, especially when pre-incubated with the venom,
but also signiﬁcantly in the prophylactic and therapeutic protocols.
Like paw edema, hind limb edema has been described as an
inﬂammatory process induced by components that involve local
mediators derived from arachidonic acid, autacoids such as hista-
mine and serotonin, and is not well blocked by antivenom (Rojas
et al., 2005; Soares et al., 1998), constituting a major complication
related to accidents caused by Bothrops in large animals.
It is known that PLA2 inhibitors, such as p-bromofenacil
bromide (p-BPB), signiﬁcantly reduced the inﬂammatory edema
induced by some Bothrops venom (Andri~ao-Escarso et al., 2000;
Landucci et al., 2000; Zuliani et al., 2005). In fact, the chemical
constituents present in the roots of the Humirianthera ampla:
diterpenoids, triterpenoids and sterols have been reported as
potent anti-inﬂammatory agents (Fernandez et al., 2001;
Hernandez-Perez et al., 1995; Liu and Lin, 2006; Yamashita
et al., 2002; Spessoto et al., 2003). In our experiments,
Humirianthera ampla extract, sitosterol and lupeol inhibited the
phospholipase and proteolytic activities of the venoms of
Bothrops atrox, Bothrops jararacussu and Bothrops jararaca in a
concentration-dependent manner, suggesting that some of the
effects observed in vivomay depend on these enzymatic activities.
It is important to state that there are no descriptions of
adverse effects or intoxication in humans following the use of
HA ethanolic crude extracts in folk medicine, which was con-
ﬁrmed by the lack of physiological complications in the animals
that received the extract both orally and intraperitoneal (data not
shown).5. Conclusion
Our study is promising because, as stated by Graebner and
colleagues (2002), Humirianthera ampla have active components,
which according to our results inhibit some properties of the
venoms of Bothrops atrox, Bothrops jararacussu and Bothrops
jararaca. Therefore, the set of our results give scientiﬁc support
for the use of Humirianthera ampla ethanolic crude extract in folk
medicine, suggesting that it can be useful as an adjuvant in the
treatment of snakebite along with the antivenom.Disclosure statement
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